Personal care company Nu Skin (NYSE: NUS) will be announcing earnings results tomorrow afternoon. Here’s what to expect.
Nu Skin beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $445.6 million, down 8.8% year on year. It was a slower quarter for the company, with revenue guidance for next quarter missing analysts’ expectations and a significant miss of analysts’ gross margin estimates.
Is Nu Skin a buy or sell going into earnings? Read our full analysis here, it’s free.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nu Skin has missed Wall Street’s revenue estimates four times over the last two years.
Looking at Nu Skin’s peers in the personal care segment, some have already reported their Q1 results, giving us a hint as to what we can expect. USANA delivered year-on-year revenue growth of 9.5%, beating analysts’ expectations by 2.7%, and Estée Lauder reported a revenue decline of 9.9%, topping estimates by 1.2%. USANA traded up 5.2% following the results while Estée Lauder’s stock price was unchanged.
Read our full analysis of USANA’s results here and Estée Lauder’s results here.
There has been positive sentiment among investors in the personal care segment, with share prices up 4.9% on average over the last month. Nu Skin is down 4% during the same time.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
